KLK15 and Alzheimer disease: In the case of the SNOTRAP/MS approach, spectral counts could be used for semiquantitative comparison between AD and Controls to identify SNO‐enzymes in the TCA cycle predominantly found in AD (Aco and DLD, representing subunit E3 of αKGDH) (Figure 1A).